Susquehanna International Group’s Organogenesis Holdings ORGO Stock Holding History

Susquehanna International Group’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,900	Closed	-$56.5K	–	12900
2024 Q1	$56.5K	Sell	19,900 -3,500	-15%	-$11.9K	﹤0.01%	11514
2023 Q4	$95.7K	Buy	+23,400	New	+$65.5K	﹤0.01%	11366
2023 Q1	–	Sell	-13,100	Closed	-$35.2K	–	13219
2022 Q4	$35.2K	Sell	13,100 -7,000	-35%	-$20.4K	﹤0.01%	11569
2022 Q3	$65K	Sell	20,100 -10,000	-33%	-$45.2K	﹤0.01%	12036
2022 Q2	$147K	Sell	30,100 -14,200	-32%	-$87.4K	﹤0.01%	11049
2022 Q1	$338K	Buy	44,300 +6,800	+18%	+$52.6K	﹤0.01%	9984
2021 Q4	$347K	Sell	37,500 -34,600	-48%	-$368K	﹤0.01%	10133
2021 Q3	$1.03M	Buy	72,100 +47,200	+190%	+$733K	﹤0.01%	7493
2021 Q2	$414K	Buy	+24,900	New	+$464K	﹤0.01%	10045

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group's ORGO Position: Q1 2026 in Review

Susquehanna International Group reduced its Organogenesis Holdings (ORGO) stake by 58% in Q1 2026, selling an estimated $135K and leaving 28,307 shares worth $67.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12533.

Susquehanna International Group first reported a position in ORGO in Q1 2019 and has held it in 20 quarters since. The position peaked at $2.63M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Susquehanna International Group held 28,307 shares of Organogenesis Holdings worth $67.1K as of Q1 2026.
Susquehanna International Group sold 39,002 Organogenesis Holdings shares in Q1 2026, an estimated $135K.
Organogenesis Holdings made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12533 holding.
Susquehanna International Group first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 20 quarters since.
Susquehanna International Group's Organogenesis Holdings position peaked at $2.63M in Q2 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.